Literature DB >> 10825425

The reduced folate carrier in L1210 murine leukemia cells is a 58-kDa protein.

R Zhao1, F Gao, L Liu, I D Goldman.   

Abstract

The reduced folate carrier (RFC1) is a major transporter for both natural reduced folates and antifolate chemotherapeutics. Using polyclonal antibodies targeted to epitopes at the loop between the sixth and seventh predicted transmembrane domains or the distal C-terminus, we were able to demonstrate by Western blot analysis that the molecular size of RFC1 expressed in murine leukemia L1210 cells is 58 kDa as predicted by the open reading frame of its cDNA. 46- and 38-kDa proteins detected only in plasma membrane preparations were proteolytic degradation products that appeared during membrane preparation or treatment with the conventional SDS-PAGE loading buffer. These data resolve discrepancies reported previously for the molecular size of RFC1.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10825425     DOI: 10.1016/s0005-2736(00)00190-5

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  5 in total

1.  Cytoplasmic domains of the reduced folate carrier are essential for trafficking, but not function.

Authors:  Heather Sadlish; Frederick M R Williams; Wayne F Flintoff
Journal:  Biochem J       Date:  2002-06-15       Impact factor: 3.857

2.  Structure and function of the reduced folate carrier a paradigm of a major facilitator superfamily mammalian nutrient transporter.

Authors:  Larry H Matherly; Zhanjun Hou
Journal:  Vitam Horm       Date:  2008       Impact factor: 3.421

3.  Transcription regulatory polymorphism -43T>C in the 5'-flanking region of SLC19A1 gene could affect rheumatoid arthritis patient response to methotrexate therapy.

Authors:  Anthoula Chatzikyriakidou; Ioannis Georgiou; Paraskevi V Voulgari; Christos G Papadopoulos; Theodoros Tzavaras; Alexandros A Drosos
Journal:  Rheumatol Int       Date:  2007-04-03       Impact factor: 2.631

4.  Tyrosine phosphorylation of HSC70 and its interaction with RFC mediates methotrexate resistance in murine L1210 leukemia cells.

Authors:  Tuoen Liu; Ratan Singh; Zechary Rios; Alok Bhushan; Mengxiong Li; Peter P Sheridan; Shawn E Bearden; James C K Lai; Senyo Agbenowu; Shousong Cao; Christopher K Daniels
Journal:  Cancer Lett       Date:  2014-11-20       Impact factor: 8.679

5.  Generation of pralatrexate resistant T-cell lymphoma lines reveals two patterns of acquired drug resistance that is overcome with epigenetic modifiers.

Authors:  Luigi Scotto; Cristina Kinahan; Beatrice Casadei; Michael Mangone; Eugene Douglass; Vundavalli V Murty; Enrica Marchi; Helen Ma; Changchun George; Francesca Montanari; Andrea Califano; Owen A O'Connor
Journal:  Genes Chromosomes Cancer       Date:  2020-07-30       Impact factor: 5.006

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.